Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Brian E Brigman"'
Autor:
Mark M. Cullen, Alexander L. Lazarides, Patricia D. Pittman, Etienne M. Flamant, Kathryn L. Stoeber, Kai Stoeber, Julia D. Visguass, Brian E. Brigman, Richard F. Riedel, Diana M. Cardona, Jason A. Somarelli, William C. Eward
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Purpose Loddo et al. (Br J Cancer 100:959–70, 2009) established the prognostic significance of cell cycle markers and "Cell-Cycle Phenotypes" in breast carcinoma. This study aims to 1) identify prognostic cell-cycle markers in sarcoma, and
Externí odkaz:
https://doaj.org/article/e9aecc8e88cd43fd9bfc3864124d0eae
Autor:
Kevin A. Wu, Devika Shenoy, Elizabeth Sachs, Jason A. Somarelli, Christian Pean, Malcolm DeBaun, Brian E. Brigman, Julia D. Visgauss, William C. Eward
Publikováno v:
BMC Musculoskeletal Disorders, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Orthopedic procedures often require removing bone or pathological tissue, with traditional methods involving instruments like curettes and rongeurs. However, these methods can be time-consuming and lead to increased blood loss. To
Externí odkaz:
https://doaj.org/article/022972d015e44269a5207e5016901d96
Autor:
Jeffrey K Mito, Richard F Riedel, Leslie Dodd, Guy Lahat, Alexander J Lazar, Rebecca D Dodd, Lars Stangenberg, William C Eward, Francis J Hornicek, Sam S Yoon, Brian E Brigman, Tyler Jacks, Dina Lev, Sayan Mukherjee, David G Kirsch
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e8075 (2009)
Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-Kras(G12D); Trp53(Flox/Flox) mouse model
Externí odkaz:
https://doaj.org/article/fc952ffe86de48899cb910a834bd347e
Autor:
Alexander L. Lazarides, Bijan Abar, Bruce Leckey, John T. Martin, Evelyna G. Kliassov, Brian E. Brigman, William C. Eward, Diana M. Cardona, Julia D. Visgauss
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Cartilaginous neoplasms can be challenging to grade; there is a need to create an evidence-based rubric for grading. The goal of this study was to identify histopathologic features of chondrosarcoma that were associated with 5-yea
Externí odkaz:
https://doaj.org/article/c43626c4778343658417837e35baa1e6
Autor:
Mark M. Cullen, Warren Floyd, Bobby Dow, Beatrice Schleupner, Brian E. Brigman, Julia D. Visgauss, Diana M. Cardona, Jason A. Somarelli, William C. Eward
Publikováno v:
Sarcoma, Vol 2024 (2024)
Purpose. Recently, the association between ATRX and a more aggressive sarcoma phenotype has been shown. We performed a retrospective study of sarcomas from an individual institution to evaluate ATRX as a prognosticator in soft tissue sarcoma. Experim
Externí odkaz:
https://doaj.org/article/44de99e458b647a394329419d9930cfa
Autor:
Saïd C. Azoury, Ronnie L. Shammas, Sammy Othman, Amanda Sergesketter, Brian E. Brigman, Jie C. Nguyen, Alexandre Arkader, Kristy L. Weber, Detlev Erdmann, L. Scott Levin, Stephen J. Kovach, Marco Innocenti
Publikováno v:
Plastic & Reconstructive Surgery. 151:805-813
Autor:
Bijan Abar, Junheng Gao, Amanda N. Fletcher, Elizbeth Sachs, Andrew H. Wong, Alexander L. Lazarides, Chinedu Okafor, Brian E. Brigman, William C. Eward, Sin‐Ho Jung, Amanda H. Kumar, Julia D. Visgauss
Publikováno v:
Journal of Orthopaedic Research.
Autor:
William C. Eward, David Needham, Jason A. Somarelli, Brian E. Brigman, David S. Hsu, Artak Tovmasyan, Ivan Spasojevic, David L. Kerr, Gireesh B. Reddy
Supplementary Materials including Text and Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22bf8967503fdd646bc1a069b3ff4544
https://doi.org/10.1158/1535-7163.22520695.v1
https://doi.org/10.1158/1535-7163.22520695.v1
Autor:
William C. Eward, David Needham, Jason A. Somarelli, Brian E. Brigman, David S. Hsu, Artak Tovmasyan, Ivan Spasojevic, David L. Kerr, Gireesh B. Reddy
Therapeutic advances for osteosarcoma have stagnated over the past several decades, leading to an unmet clinical need for patients. The purpose of this study was to develop a novel therapy for osteosarcoma by reformulating and validating niclosamide,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb56fcf9e01bab0e3faabaa7bef0b49
https://doi.org/10.1158/1535-7163.c.6542728.v1
https://doi.org/10.1158/1535-7163.c.6542728.v1
Autor:
Alexander L. Lazarides, Etienne M. Flamant, Mark M. Cullen, Harrison R. Ferlauto, Niall Cochrane, Junheng Gao, Sin‐Ho Jung, Julia D. Visgauss, Brian E. Brigman, William C. Eward
Publikováno v:
Journal of Surgical Oncology. 126:356-364
Little is known about the drivers of readmission in patients undergoing Orthopaedic oncologic resection. The goal of this study was to identify factors independently associated with 90-day readmission for patients undergoing oncologic resection and s